TRICYCLIC PARP1 INHIBITORS AND THEIR APPLICATIONS
EA054669B1Active Publication Date: 2026-09-24XINTHERA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- EA202591110
- Authority / Receiving Office
- EA · EA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-10-28
- Filing Date
- 2023-04-27
- Publication Date
- 2026-09-24
- Estimated Expiration
- 2043-04-27
Smart Images
Figure CLAIM-24092026-IMGC0001 
Figure CLAIM-24092026-IMGC0002
Abstract
This document describes tricyclic PARP1 inhibitors and pharmaceutical compositions containing said inhibitors. The compounds and compositions are useful for the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art
Claims
1. Connection or its pharmaceutically acceptable salt or tautomer.
2. The compound according to claim 1, wherein the compound is 3. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound according to claim 1, or a pharmaceutically acceptable salt or tautomer thereof.
4. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound according to claim 2.